CLINICAL ROLE -
Trending News Today: Opioid Lawsuit Garners Federal Support
Top news of the day from across the health care landscape.
Read More
Health Care Spending Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
New Potential Way to Combat Influenza Highlights AJPB Week in Review
Diabetes Organ Damage Highlights AJPB Week in Review
Imodium Packaging Update Highlights AJPB Week in Review
Pharmacy Week in Review: February 2, 2018
A look at last week's top stories in the world of pharmacy.
CDC Warns Influenza Cases, Related Deaths Still Increasing
CDC officials said this year’s influenza season may be peaking, but it will likely take several more weeks before activity slows down.
FDA Approves Treatment for Irritable Bowel Syndrome With Constipation
Plecanatide has already been approved for the treatment of chronic idiopathic constipation.
Opioid Labeling Changes Highlights AJPB Week in Review
Metformin Adherence Highlights AJPB Week in Review
Pharmacy Week in Review: January 5, 2018
FDA Approves Treatment for Low Blood Pressure from Septic Shock
Angiotensin II injection approved for intravenous infusion to treat dangerously low blood pressure in adults with septic or other distributive shock.
Top Drug Approvals in 2017 Highlights AJPB Week in Review
FDA Approves Novel SGLT2 Inhibitor for Type 2 Diabetes
Ertugliflozin (Steglatro) is also approved as part of 2 fixed-dose combinations.
Asthma Drug Boxed Warning Highlights AJPB Week in Review
Bipolar Depression Drug Shows Promise in Clinical Trials
Cariprazine is an oral atypical antipsychotic currently approved for the acute treatment of adults with manic or mixed episodes associated with bipolar I disorder.
FDA Rules Target OTC Antiseptic Soaps
Some health care antiseptics currently on the market won’t be affected by FDA decision.
Influenza Concerns Highlights AJPB Week in Review
Teva Announces Launch of Generic Viagra
Sildenafil tablets are a phosphodiesterase-5 inhibitor indicated for the treatment of erectile dysfunction.
Long-Acting COPD Treatment Gets FDA Approval
Glycopyrrolate inhalation solution is the first nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease.
Opioid Use Disorder Drug Approval Highlights AJPB Week in Review
Medicare Policy Changes Highlights AJPB Week in Review
FDA Approval of Opioid Withdrawal Device Highlights AJPB Week in Review
Pharmacy Week in Review: November 17, 2017
Schizophrenia Maintenance Therapy Gets FDA Approval
Cariprazine is a once-daily atypical antipsychotic for patients with bipolar I disorder and schizophrenia.
Early Surge of ACA Enrollment Highlights AJPB Week in Review
Pharmacy Week in Review: November 10, 2017
FDA Expands Indication for Auryxia to Treat Iron Deficiency, Kidney Disease
Ferric citrate was originally approved for the control of serum phosphorus levels in patients with chronic kidney disease who require dialysis.
Pharmacy Week in Review: November 3, 2017
FDA Approves Rivaroxaban for Recurrent Venous Thromboembolism
Xarelto reduces the continued risk for recurrent venous thromboembolism after completing at least 6 months of initial anticoagulation therapy.